Rubicon Research IPO Allotment Date
As per the timeline, the Rubicon Research IPO allotment date is October 14, 2025, Tuesday. The investors can check the IPO allotment via the registrar website of MUFGIntime or the BSE, NSE website. Investors can check the allotment status online and offline with easy steps given below:
Rubicon Research IPO Allotment Links
| Registrar: | MUFGIntime IPO Allotment Page |
| BSE: | BSE IPO Allotment Page |
| NSE: | NSE IPO Allotment Page |
| IPO Watch: | IPO Allotment Status Page |
Check Rubicon Research’ IPO Allotment Status on Registrar site?
- Visit MUFG Intime India Pvt.Ltd. website
- Select IPO Name ‘Rubicon Research’ from the drop-down menu on the page
- Enter details required like PAN Card, Application Number, or Demat Account Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Rubicon Research IPO Allotment Status on BSE?
- Visit BSE India IPO Allotment Page
- Select the issue type: equity/debt
- Select IPO Name ‘Rubicon Research’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
Check Rubicon Research IPO Allotment Status on NSE?
- Visit NSE India IPO Allotment Page
- Select the issue type
- Select IPO Name ‘Rubicon Research’ from the drop-down menu on the page
- Enter details required like PAN Card or Application Number
- Click on the ‘Search’ Button, and;
- Get your allotment on the your screen
IPO Subscription Details
| Category | Day 1 | Day 2 | Day 3 |
| QIB | – | – | – |
| NII | – | – | – |
| RII | – | – | – |
| Total | – | – | – |
Rubicon Research IPO Key Dates
| IPO Open Date: | October 9, 2025 |
| IPO Close Date: | October 13, 2025 |
| Basis of Allotment: | October 14, 2025 |
| Refunds: | October 15, 2025 |
| Credit to Demat Account: | October 15, 2025 |
| IPO Listing Date: | October 16, 2025 |
Business Overview
Rubicon Research is one of the leading pharmaceutical formulations companies and focuses on innovation through dedicated research and development. Moreover, their portfolio includes specialty products and drug-device combination products, aimed mainly at regulated markets, especially the United States.
Furthermore, they believe their multi-disciplinary, data-driven, and return on investment (“ROI”) centric product selection framework is geared towards identifying sustainable opportunities for new product development. Moreover, they find and go after opportunities that give an edge by using skills in development, manufacturing, and sales to grow market share.
The company has unique strengths, the Fastest-growing Indian pharmaceutical company compared to peers, a Data-driven way to choose products, a Strong research and development team, Solid sales and distribution network in the US.
Note for the Investors
Rubicon Research IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Rubicon Research IPO Allotment date and time please contact the registrar with your queries.
